At a glance
- Originator Nonindustrial source
- Class Anticoagulants; Antifungals; Thrombolytics
- Mechanism of Action Plasminogen activator stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 23 Sep 1998 No-Development-Reported for Thrombosis in Japan (Unknown route)
- 28 Nov 1996 New profile
- 28 Nov 1996 Preclinical development for Thrombosis in Japan (Unknown route)